When he said this, everyone was in trouble. They were technical staff, Medtronic’s heart stent, and the demand was considerable.
Patients with financial strength often choose imported stents. The heart stents that are agents of Medtronic are also an important source of income for Asuvian Group.
Now the original factory is asking for an increase in price, but they have no bargaining ability, so they can only choose not to accept it, because in addition to them, other agents also want to represent the heart stent of this brand.
"Send notifications to hospitals and subordinate agents to increase the price." A deputy general manager named Wang said, "We must ensure our profit margin."
"Doing this will definitely reduce our market share." Director Jia of the sales department did not agree very much. "Our cooperation with hospitals and subordinate agents is not just a heart stent, but also other medical devices. If our sales channels are reduced because of this, we may lose more!"
"Then, the price remains unchanged. How about adjusting the product structure?" Director Song of the Product Department suggested, "increase the sales share of self-produced heart stents and reduce the sales ratio of imported stents."
"If you do this, you are good, but you are afraid that the profit will drop a lot." The director of the Production Service Department said helplessly, "The market competitiveness of our own heart stents is probably not enough."
There are several types of heart stents, and the one used most now is permanent stents of metal materials. This stent may cause complications, such as inflammation of foreign bodies, which will require patients to take anticoagulants throughout their lives.
Imported heart stents, which are used for a long time, are metal stents that have been treated with drugs, and the effect is better than the first one.
There is also a more advanced one, which is bioabsorbable stent. Heart stents made with soluble materials that are harmless to the human body have similar effects as drug-coated stents, but they can dissolve by themselves after the acute disease period, avoiding adverse reactions to local inflammation.
This bioabsorbable stent technology is basically in the hands of foreign medical technology companies. The domestic stent of Feiniao Group can only reach the level of drug-coated stents at most.
"It is necessary to reduce the proportion of imported stents." Su Xueyan said, "At the same time, the price should be adjusted. I have emphasized a long time ago that we cannot be stuck by them all the time! We must also improve our medical device technology!"
Everyone was silent and thought to themselves, it was easy to say. If it was so easy to bring it up, who would have found a foreign brand agent? They made money by relying on this technology!
"I want to tell you something here." Su Xueyan paused and said, "I was invited to participate in the Huajin Industrial Science and Technology Exhibition last time, do you know?"
"I know!" Everyone nodded.
"I got a big gain when I went there! I discovered a domestic manufacturing company, and their manufacturing level was quite high!" Su Xueyan continued, "I personally inspected it, and then sent colleagues from the R&D department to inspect it again."
"I decided to work with this company to develop a new technology, 3D printing of heart stents. Note that it is not a metal stent, but a new generation of bioabsorbable heart stents!"
"Yes, we have been preparing for this matter for a while!" Zhu Jia, director of the R&D department, said.
Several senior executives here know about this, but they don’t care. After all, there are so many projects in the R&D department, and there are many projects that have died in the middle, but they have not produced finished products, which cannot be used as a quantitative reference for them.
"This company is called Z Time and Space, you can learn about it now." Su Xueyan asked his assistant to send the information to everyone.
"Z Time and Space? This company has been established for a short time." A vice president briefly browsed and said.
"Yes, it has not been established for a long time, but the technology is good." Su Xueyan said affirmatively.
"Mr. Su, I would like to ask, I saw that the investment amount of this project has been added, most of which will be delivered to Z time and space. Can they provide corresponding technical services?" asked a deputy general manager and shareholder.
"I also have this problem. I read this information. Mr. Su, you are planning to focus on 3D printing and manufacturing heart stents. This project does not seem to be successful." Director Song of the product department also raised questions.
"At present, although there are such precedents abroad, there are no formal projects to be put into production. I doubt we can do it?"
"If you take too much, you will lose unnecessary funds."
"Let me answer this on behalf of President Su." Zhu Jia from the R&D Department said, "To be honest, when President Su just told me about this, I strongly opposed it."
"Later, I took the R&D personnel to visit their factories and equipment in person. After experiencing their 3D printing technology, I think it is completely feasible!"
"You are not doing research and development, and you may not know. Making a heart stent requires manufacturing accuracy, material processing and structure design, and this is the difficulty."
"And they have the strength to solve these three problems! That's why I agree with Mr. Su's point of view. This may be our opportunity. If the project is successful, we can make our own biosoluble heart stents to get rid of one of Medtronic's technical squeezes on us!"
"Is this true?" the senior executives were surprised. "There is such a thing?"
"Director Zhu, I still find it hard to believe that you said so!" Director Song of the Products Department continued, "If there is such technology, why can Medtronic not do it, a domestic 3D printer company be able to do it?"
"Besides, our own group's R&D department has been developing for so many years. Is it just a printer company in manufacturing?"
"It's not a printer, it's a 3D printer!" Su Xueyan emphasized, "I think you can see more new technologies in the future, which will be very helpful for our work and decision-making."
"Just three days ago, news came from Z time and space that they had made a 3D heart stent printer that could print soluble materials and would be sent to the company for experiments soon."
"How to make our heart stent sales strategy after the experiment!"
The meeting ended, and Su Xueyan took the lead in taking the initiative, but several other senior officials were still discussing.
"3D printing? I see it!" said Director Song of the Product Department. "I have made many statements with American companies, and I know their products very well. It is not realistic to use 3D printing technology to make heart stents!"
Chapter completed!